Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations
Patent and Exclusivity Search Results from query on Appl No 020031 Product 003 in the OB_Rx list.
|Appl No||Prod No||Patent No||Patent
|N020031||003||5872132||May 19, 2015|
|N020031||003||5872132*PED||Nov 19, 2015|
|N020031||003||5900423||May 19, 2015|
|N020031||003||5900423*PED||Nov 19, 2015|
|N020031||003||6113944||Dec 14, 2014|
|N020031||003||6113944*PED||Jun 14, 2015|
|N020031||003||6121291||Mar 17, 2017||U - 286|
|N020031||003||6121291||Mar 17, 2017||U - 431|
|N020031||003||6121291*PED||Sep 17, 2017|
|N020031||003||6133289||May 19, 2015||U - 358|
|N020031||003||6133289*PED||Nov 19, 2015|
There is no unexpired exclusivity for this product.
- Patents are published upon receipt by the Orange Book Staff and may not reflect the official receipt date as described in 21 CFR 314.53(d)(5).
- Patents listed prior to August 18, 2003 are flagged with method of use claims only as applicable and submitted by the sponsor. These patents may not be flagged with respect to other claims which may apply.
View a list of all patent use codes
View a list of all exclusivity codes
FDA/Center for Drug Evaluation and Research
Office of Generic Drugs
Division of Labeling and Program Support
Orange Book Data - Monthly
Generic Drug Product Information & Patent Information - Daily
Orange Book Data Updated Through March 2015
Patent and Generic Drug Product Data Last Updated April 24, 2015